SCHEMBL26961950

SCHEMBL26961950

CC(C)(C)OC(=O)N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(C4CNCC(F)(F)C4)o3)cc2N(Cc2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ GRM2 Q14416 1/20 0.32
▸ KCNN4 O15554 1/20 0.32
▸ GCGR P47871 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26961829 0.93 XIAP (0.32) —
SCHEMBL26961949 0.90 GRM2 (0.32) GRM2KCNN4GCGR
SCHEMBL26961664 0.86 GCGR (0.35) GRM2KCNN4GCGR
SCHEMBL26962135 0.84 ABHD6 (0.33) —
SCHEMBL26961880 0.84 KCNN4 (0.33) GRM2KCNN4GCGR
SCHEMBL26961939 0.83 NPY1R (0.30) —
SCHEMBL26961600 0.83 P2RX3 (0.31) —
SCHEMBL26961787 0.82 XIAP (0.32) —
SCHEMBL26961790 0.81 KCNH2 (0.34) —
SCHEMBL26961640 0.80 NPY1R (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291558-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2023-12-20 — — EP disclosed
Send feedback